Perspective: Failing the Public Health — Rofecoxib, Merck, and the FDA
5 Oct, 2018 | 01:45h | UTCFailing the Public Health — Rofecoxib, Merck, and the FDA – New England Journal of Medicine (free)
Failing the Public Health — Rofecoxib, Merck, and the FDA – New England Journal of Medicine (free)